The Effect of Local Corticosteroid Injection on Electrophysiological and Ultrasonographic Findings in Carpal Tunnel Syndrome Patients With Type 2 Diabetes
Our study was planned as a prospective observational study aiming to compare the post-intervention recovery process between patients with carpal tunnel syndrome (CTS) and diabetes mellitus and patients with idiopathic carpal tunnel syndrome without diabetes mellitus. Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and who were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological findings and who received corticosteroid + local anesthetic injection will be included in the study. Data from patients who meet the inclusion and exclusion criteria will be included in the study. Patients' demographic and clinical data will be recorded. Records will be taken before treatment and at 4 and 12 weeks after treatment.
• Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1):
‣ Age between 18 and 75 years
⁃ Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
⁃ Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
⁃ Diagnosis of type 2 diabetes mellitus
⁃ Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7%
• Idiopathic Carpal Tunnel Syndrome Group (Group 2):
‣ Age between 18 and 75 years
⁃ Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
⁃ Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
⁃ No diagnosis of diabetes mellitus